Variable (N*) | Death within 500 days | Survival of 500 days | p-value univariate | p-value multivariate | |
---|---|---|---|---|---|
 | N (%) |  |  |  |  |
Risk factors | Â | Â | Â | Â | Â |
CAD (465*/479) | 144 (31%) | 54 (37.5%) | 90 (62.5%) | p=0.02 | p=0.01 |
MI (475*/479) | 84 (17.7%) | 33 (39.3%) | 51 (60.7%) | p=0.07 | Â |
Heart failure (452*/479) | 169 (37.4%) | 62 (36.7%) | 107 (63.3%) | p=0.01 | p=0.94 |
PAD (461*/479) | 48 (10.4%) | 23 (47.9%) | 25 (52.1%) | p=0.004 | p=0.13 |
Hypertension (479*/479) | 446 (93.1%) | 136 (30.5%) | 310 (69.5%) | p=0.70 | Â |
Diabetes (478*/479) | 157 (32.8%) | 43 (27.4%) | 114 (72.6%) | p=0.34 | Â |
Hypercholesterolemia (470*/479) | 285 (60.6%) | 79 (27.7%) | 206 (72.3%) | p=0.26 | Â |
Smoking (400*/479) | Â | Â | Â | p=0.24 | Â |
Nonsmoker | 206 (51.5%) | 69 (33.5%) | 137 (66.5%) | Â | |
Smoker | 42 (10.5%) | 11 (26.2%) | 31 (73.8%) | Â | |
Former smoker | 152 (38%) | 39 (25.7%) | 113 (74.3%) | Â | |
GFR (461*/479) | Â | Â | Â | p<0.0001 | p=0.09 |
0-<30 | 16 (3.5%) | 8 (50%) | 8 (50%) | Â | Â |
30-<60 | 160 (34.7%) | 66 (41.3%) | 94 (58.7%) | ||
60 | 285 (61.8%) | 65 (22.8%) | 220 (77.2%) | ||
Treatment (479*/479) | Â | Â | Â | Â | Â |
Intraveneous thrombolysis | Â | Â | Â | p=0.62 | Â |
Yes | 47 (9.8%) | 16 (34%) | 31 (66%) | Â | Â |
No | 432 (90.2) | 131 (30.3) | 301 (69.7) | Â | |
Antithrombotic treatment (479*/479) | Â | Â | Â | Â | Â |
OAK prior to stroke | 116 (24.2%) | 20 (17.2%) | 96 (82.8%) | p=0.0003 | p=0.91 |
INR <2 | 65 (58%) | 15 (23.1%) | 50 (76.9%) | Â | Â |
INR ≥2 | 44 (39.3%) | 4 (9.1%) | 40 (90.9%) |  |  |
INR unknown | 7 (6%) | 1 (14.3%) | 6 (85.7%) | Â | Â |
Antiplatelets prior to stroke (479*/479) | Â | Â | Â | p<0.0001 | Â |
No antiplatelet | 298 (62.2%) | 69 (23.2%) | 229 (76.8%) | Â | Â |
Antiplatelet | 181(37.8%) | 78 (43.1%) | 103 (56.9%) | Â | |
OAC management post stroke (479*/479) | Â | Â | Â | p<0.0001 | p<0.0001 |
No VKA | 200 (41.8%) | 127 (63.5%) | 73 (37.5%) | ||
OAC neither given, nor recommended | 158 (79%) | 109 (69%) | 49 (31%) | ||
OAC recommended, but not given | 42 (21%) | 18 (42.9%) | 24 (57.1%) | ||
VKA started in hospital | 181 (37.8%) | 16 (8.8%) | 165 (91.2%) | ||
VKA started post discharge | 71 (14.8%) | 2 (2.8%) | 69 (97.2%) | ||
Unknown | 27 (5.6%) | 2 (7.4%) | 25 (93.6%) | ||
Recurrent cerebral event (500days) | 43/479 (9%) | 21 (48.8%) | 22 (51.2%) | p=0.009 | p=0.27 |
IS | 33 (76.7%) | 19 (57.6%) | 14 (42.4%) | ||
TIA | 6 (14%) | 0 | 6 | ||
ICH | 4 (9.3%) | 2 (50%) | 2 (50%) |